Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutogliptin in Type 2 Diabetes on Metformin
NCT00850239Phase 3Terminated
- Sponsor
- Phenomix Sciences
- Start
- May 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of dutogliptin in type 2 diabetes mellitus (T2DM), sponsored by Phenomix Sciences. Started May 2009; status: terminated.
02
Drugs
dutogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00850239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00850239.